Humana expands board to 14, elects David Feinberg under Starboard agreement

HUMANA INC

Board expanded from 13 to 14 directors; David T. Feinberg, M.D. elected effective March 1, 2022.
Dr. Feinberg is President, CEO and board member of Cerner; previously led Google Health and Geisinger Health.
Appointment made under agreement with Starboard Value LP dated February 21, 2022.
Dr. Feinberg will receive standard director compensation plus RSUs under Humana's director program.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David T. Feinberg

Director

HUM · HUMANA INC

Effective: 2022-03-01
Filed: March 1, 2022, 6:59 PM ET

Effective March 1, 2022, the Board of Directors (the “Board”) of Humana Inc. (the “Company”) expanded its number of authorized directors from thirteen to fourteen and elected David T. Feinberg, M.D. as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David T. Feinberg was elected as Director at HUMANA INC.

Action: elected
Role: Director

Exact text from the filing

Effective March 1, 2022, the Board of Directors (the “Board”) of Humana Inc. (the “Company”) expanded its number of authorized directors from thirteen to fourteen and elected David T. Feinberg, M.D. as a director of the Company.

View on SEC.gov

HUMANA INC filing history →

Source: SEC EDGAR

accession 0000049071-22-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.